Britton, "Corticotropin
releasing factor, stress and behavior," Seminars in Neuroscience, vol.
Urocortin 2 is associated with abdominal aortic aneurysm and mediates anti-proliferative effects on vascular smooth muscle cells via corticotrophin
releasing factor receptor 2.
Hypothalamic cocaine- and amphetamine-regulated transcript and corticotrophin
releasing factor neurons are stimulated by extracellular volume and osmotic changes.
Role of corticotropin
releasing factor receptor subtype 1 in stress-related functional colonic alterations: implications in irritable bowel syndrome.
Design and biological activity of analogs of growth hormone
releasing factor with potential amphiphilic helical carboxyl termini.
El resultado directo es un aumento en la liberacion de glucocorticoides y en el Factor Liberador de Corticotropina (Corticotropin
Releasing Factor, CRF) [12], el cual disminuye la contrarregulacion derivada de la accion del receptor de glucocorticoide [9], los cuales se encargan de la normalizacion de la actividad despues de la despolarizacion por medio de acciones en la membrana y en los receptores nucleares [16].
The Phase 2 trial, which involved 150 patients experiencing a major depressive episode, found no benefit for patients treated with the experimental drug, a corticotropin
releasing factor (CRF1) receptor antagonist called GSK561679.
The detection of the neuropeptides of CRF family (Corticotropin
Releasing Factor) and selective receptors in the gastrointestinal tract has made clearer the role of HPA (HypothalamusPituitary-Adrenals) axis in brain-gut syndromes.
Metabolic effects of a growth hormone-
releasing factor in patients with HIV.
In this study, the multiply charged ions were generated using four peptide standards; Porcine Growth Hormone
Releasing Factor (GRF) FW:5108.76, Glucagon-Like Peptide (GLP) FW: 3297.63, C-Type Natriuretic Peptide FW:2197.6 (Sigma Chemicals, St Louis, Missouri, USA) and a proprietary peptide, FW:1282.
In addition, NA stimulation is associated with the lightening of types of sleep other than REM and increased levels of corticotrophin
releasing factor (CRF).
Their topics include the life cycle of depression, considerations of cognitive, psychodynamic, and cognitive-behavioral theories, the role of development and its implications in childhood and adolescent depression, developments in psychodynamic development psychopathology such as complex developmental pathways, and the integration of psychology and neurobiology in such treatment tools as corticotropin
releasing factor. The concluding article explores the idea that now is the time for integration in the theory and treatment of depression.